Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Jul 22;23(15):8082.
doi: 10.3390/ijms23158082.

Ceramide/Sphingosine 1-Phosphate Axis as a Key Target for Diagnosis and Treatment in Alzheimer's Disease and Other Neurodegenerative Diseases

Affiliations
Review

Ceramide/Sphingosine 1-Phosphate Axis as a Key Target for Diagnosis and Treatment in Alzheimer's Disease and Other Neurodegenerative Diseases

Antía Custodia et al. Int J Mol Sci. .

Abstract

Alzheimer's disease (AD) is considered the most prevalent neurodegenerative disease and the leading cause of dementia worldwide. Sphingolipids, such as ceramide or sphingosine 1-phosphate, are bioactive molecules implicated in structural and signaling functions. Metabolic dysfunction in the highly conserved pathways to produce sphingolipids may lead to or be a consequence of an underlying disease. Recent studies on transcriptomics and sphingolipidomics have observed alterations in sphingolipid metabolism of both enzymes and metabolites involved in their synthesis in several neurodegenerative diseases, including AD. In this review, we highlight the most relevant findings related to ceramide and neurodegeneration, with a special focus on AD.

Keywords: Alzheimer’s disease; ceramide; metabolism; sphingolipidomics; sphingolipids; sphingosine 1-phosphate; tau; β-amyloid.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Sphingolipid metabolism. Single reactions are represented by solid arrows, while multiple-step reactions are shown as dashed arrows. Interrogation marks with dashed arrows point to possible mechanisms not yet described. Serine palmitoyltransferase (SPT), 3-keto-dihydrosphingosine reductase (KDR), ceramide Synthase (CerS) and dihydroceramide desaturase (DEGS), sphingomyelinase (SMase), acid sphingomyelinase (aSMase), sphingomyelin synthase (SMS), acid β-glucosidase (β-GCase), glucosylceramide synthase (GCS), ceramide synthase (CerS), sphingosine kinase (SphK), and sphingosine 1-phosphate phosphatase (SPP) are represented by their acronyms.
Figure 2
Figure 2
Involvement of Cer in Alzheimer’s disease. Several pieces of evidence support the involvement of Cer in the progression of AD, as it is interrelated with the formation of Aβ (A) and its neurotoxicity (B). Cer also plays a role in lipid peroxidation (C) and neuroinflammation (D) p75 neurotrophin receptor (P75NTR), β-secretase (BACE-1), amyloid precursor protein (APP), sphingomyelinase (SMase), β-amyloid (Aβ), ceramide (Cer), nitric oxide (NO), sphingosine 1-phosphate (S1P), pro-apoptotic protein Bcl-2-associated X protein (BAX), mitochondrial voltage-dependent anion channel 1 (VDAC-1), 4-Hydroxynonenal (HNE), nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB), inducible nitric oxide synthase (iNOS), glial fibrillary acidic protein (GFAP), tumor necrosis factor α (TNF-α), interleukin-6 (IL-6), and interleukin-1β (IL-1β).

References

    1. World Health Organization (WHO) Global Action Plan on the Public Health Response to Dementia 2017–2025. Volume 27 World Health Organization; Geneva, Switzerland: 2017.
    1. Atri A. The Alzheimer’s Disease Clinical Spectrum: Diagnosis and Management. Med. Clin. N. Am. 2019;103:263–293. doi: 10.1016/j.mcna.2018.10.009. - DOI - PubMed
    1. Javaid S.F., Giebel C., Khan M.A., Hashim M.J. Epidemiology of Alzheimer’s Disease and Other Dementias: Rising Global Burden and Forecasted Trends. F1000Research. 2021;10:425. doi: 10.12688/f1000research.50786.1. - DOI
    1. Nichols E., Abd-Allah F., Abdoli A., Abosetugn A.E., Abrha W.A., Abualhasan A., Abu-Gharbieh E., Akinyemi R.O., Alahdab F., Alanezi F.M., et al. Global Mortality from Dementia: Application of a New Method and Results from the Global Burden of Disease Study 2019. Alzheimer’s Dement. Transl. Res. Clin. Interv. 2021;7:e12200. doi: 10.1002/TRC2.12200. - DOI - PMC - PubMed
    1. Gallardo G., Holtzman D.M. Amyloid-β and Tau at the Crossroads of Alzheimer’s Disease. Adv. Exp. Med. Biol. 2019;1184:187–203. doi: 10.1007/978-981-32-9358-8_16. - DOI - PubMed

MeSH terms